ArticleCancer chemotherapy and pharmacologyPublished
Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL)
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Cancer chemotherapy and pharmacology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Piperidines; Pyrazoles; Pyrimidines; Adenine; Protein Kinase Inhibitors; Dose-Response Relationship, Drug; Models, Biological; Aged; Middle Aged; Female; Male
- PubMed ID
- 40019563
- PubMed Central ID
- PMC11870975
- Open access
- Yes, open
- Added to directory
- Source checked